论文部分内容阅读
目的 :针对慢性萎缩性胃炎患者应用阿莫西林联合果胶铋治疗的临床效果进行观察。方法 :抽取本院于2014年10月至2016年4月收治的120例患有慢性萎缩性胃炎的患者进行研究,并随机将所有患者划分为观察组60例,和对照组60例。其中,对照组患者应用本院常用的克拉霉素联合果胶铋加以治疗,而观察组患者则应用阿莫西林联合果胶铋加以治疗。以此对两组患者的临床治疗效果进行比较分析。结果 :经治疗,观察组患者的治疗总有效率为94%,相比对照组患者78%的总有效率显著更高,组间差异明显(P<0.05),有统计学意义。并且,观察组患者的治疗痊愈率为70%,对比对照组患者48%的痊愈率显著更高,两组数据差异明显(P<0.05),有统计学意义。结论 :应用阿莫西林联合果胶铋治疗慢性萎缩性胃炎所取得的效果非常明显,可有效提升患者痊愈率,对于患者的快速痊愈而言,意义重大。因此,值得在临床中应用及推广。
Objective: To observe the clinical effect of amoxicillin combined with pectin bismuth in patients with chronic atrophic gastritis. Methods: A total of 120 patients with chronic atrophic gastritis who were treated in our hospital from October 2014 to April 2016 were selected and randomly divided into the observation group (60 cases) and the control group (60 cases). Among them, patients in the control group were treated with commonly used clarithromycin combined with bismuth pectate in our hospital, and patients in the observation group were treated with amoxicillin combined with bismuth pectin. In order to compare the clinical effects of two groups of patients. Results: After treatment, the total effective rate was 94% in the observation group and 78% in the control group. The total effective rate was significantly higher (P <0.05), which was statistically significant. Moreover, the cure rate of observation group was 70%, and the recovery rate of 48% in control group was significantly higher than that of control group (P <0.05), which was statistically significant. Conclusion: The effect of amoxicillin combined with bismuth pectin in the treatment of chronic atrophic gastritis is very obvious, which can effectively improve the cure rate of patients, which is of great significance for the rapid recovery of patients. Therefore, it is worth in clinical application and promotion.